Log in

Relevant bibliographies by topics / Drugs Prescribing China Hong Kong

Academic literature on the topic 'Drugs Prescribing China Hong Kong'

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Journal articles
Dissertations / Theses
Books
Book chapters

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drugs Prescribing China Hong Kong.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drugs Prescribing China Hong Kong"

1

Yuen, WC, WF Tang, and CH Chung. "Substance Abuse Patient Characteristics: A Scene from an Emergency Department near the Hong Kong – Shenzhen Border." Hong Kong Journal of Emergency Medicine 8, no. 4 (October 2001): 196–201. http://dx.doi.org/10.1177/102490790100800402.

Full text

Abstract:

Objective Drug abuse is an escalating problem in Hong Kong, especially among teenagers and young adults. A study was conducted in order to obtain the characteristics of drug abusers presenting to the Accident & Emergency department of North District Hospital, which is located in the New Territories near the Hong Kong – Shenzhen border. Design Prospective study. Setting Accident and Emergency department of a public general hospital. Patients Drug abusers presenting to the Accident and Emergency department in a six-month period. Main outcome measures Epidemiological data including demographic data, types of drug taken, place of drug abuse and magnitude of cross-border drug abuse were collected and analyzed. Results The sex distribution was male 59 and female 13 (ratio=4.5:1). The mean age was 29.2 (range 14 to 67 years). Of interest, 29.2% abused drugs at home; 29.2% abused drugs in parties such as karaoke, rave and disco; 68% abused drugs in Hong Kong; 32% abused drugs in China and 6.9% claimed themselves first-time drug abusers. The commonest drug taken was ecstasy (40.3%) – the majority (55%) in China and the rest (45%) in Hong Kong. For organic solvent abusers, 57.1% were below 18 years of age. One patient died, resulting in a mortality rate of 1.4%. Conclusion Ecstasy was the commonest drug abused on both sides of the “border”. The majority of substance abusers were teenagers or young adult males. This study confirmed the significant magnitude of psychotropic substance abuse problem among the young population in the North District, indicating the urgent need for clinical and social intervention.

APA, Harvard, Vancouver, ISO, and other styles

2

Luk, Kristine Shik, Yat-ming Tsang, Alex Yat-man Ho, Wing-kin To, Ben Kwok-ho Wong, Maureen Mo-lin Wong, and Yiu-chung Wong. "Invasive Burkholderia cepacia Complex Infections among Persons Who Inject Drugs, Hong Kong, China, 2016–2019." Emerging Infectious Diseases 28, no. 2 (February 2022): 323–30. http://dx.doi.org/10.3201/eid2802.210945.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Shek, Daniel T. L., Britta M. Lee, and Joyce Chow. "Trends in Adolescent Suicide in Hong Kong for the Period 1980 to 2003." Scientific World JOURNAL 5 (2005): 702–23. http://dx.doi.org/10.1100/tsw.2005.83.

Full text

Abstract:

This paper utilizes existing statistics on adolescent suicide to examine adolescent suicide trends and patterns in Hong Kong for the period 1980 to 2003. Several trends and patterns could be revealed from the analyses. First, there was a gradual rising trend where adolescent suicide rates in the 1990's and the early 2000's were higher than those in the 1980's. Second, suicide rates for adolescents aged 10-24 years were lower than those of other adult age groups. Third, although adolescent suicide rates in Hong Kong were lower than those reported in some English-speaking countries and Mainland China, the figures were higher than those reported in Taiwan. Fourth, suicide rates among teenagers in early adolescence were lower than those among adolescents in late adolescence. Fifth, although male adolescent suicide rates were in general higher than female adolescent suicide rates (10-24 age group), gender differences in suicide rates appeared to be moderated by age. Sixth, there was a gradual rising trend in adolescent proportional mortality rates for suicide since the 1990's. Seventh, proportional mortality rates for suicide among teenagers in early adolescence were lower than those among adolescents in late adolescence. Finally, although jumping from a height was a common method of adolescent suicide, there was a rising trend of using other methods, such as taking drugs, hanging and charcoal burning. The observed adolescent suicide phenomena are discussed in this study with reference to the socio-cultural context of Hong Kong.

APA, Harvard, Vancouver, ISO, and other styles

4

Xiang, Yu-Tao, Faith Dickerson, Julie Kreyenbuhl, Gabor S. Ungvari, Chuan-Yue Wang, Tian-Mei Si, Edwin H. M. Lee, et al. "Prescribing patterns of low doses of antipsychotic medications in older Asian patients with schizophrenia, 2001–2009." International Psychogeriatrics 24, no. 6 (February 3, 2012): 1002–8. http://dx.doi.org/10.1017/s1041610211002791.

Full text

Abstract:

ABSTRACTBackground: This study examined the use of low doses of antipsychotic medications (300 mg/day CPZeq or less) in older Asian patients with schizophrenia and its demographic and clinical correlates.Methods: Information on hospitalized patients with schizophrenia, aged 55 years or older, was extracted from the database of the Research on Asian Psychotropic Prescription Patterns (REAP) study (2001–2009). Data on 1,452 patients in eight Asian countries and territories including China, Hong Kong, Japan, Korea, Singapore, Taiwan, India, and Malaysia were analyzed. Sociodemographic and clinical characteristics and antipsychotic prescriptions were recorded using a standardized protocol and data collection procedure.Results: The prescription frequency for low doses of antipsychotic medications was 40.9% in the pooled sample. Multiple logistic regression analysis of the whole sample showed that patients on low doses of antipsychotic medications were more likely to be female, have an older age, a shorter length of illness, and less positive symptoms. Of patients in the six countries and territories that participated in all the surveys between 2001 and 2009, those in Japan were less likely to receive low doses of antipsychotics.Conclusion: Low doses of antipsychotic medications were only applied in less than half of older Asian patients with schizophrenia.

APA, Harvard, Vancouver, ISO, and other styles

5

Hu, Shiu Ying. "Herbal Teas and Populace Health Care in Tropical China." American Journal of Chinese Medicine 25, no. 01 (January 1997): 103–34. http://dx.doi.org/10.1142/s0192415x97000147.

Full text

Abstract:

Commercial Chinese herbal tea is the development of the populace in tropical and subtropical China consequential to their fight against infectious diseases and in their struggle to explore local plants to relieve fever, to alleviate pain, to restore strength and to modulate immunity against viral epidemics. From these ethnomedical experiences, two types of herbal teas were commercialized, namely, liangcha and medicated teas. Liangcha refers to a ready-made decoction infused from wild plants served in simple stores in cities and towns. Medicated teas are parcelled material prepared from crude drugs with or without tea (Camellia sinensis [L.] O. Ktze,), sold in colorful boxes and bags to people for use at home. Investigations of liangcha were made in Hong Kong and Macao, and studies of medicated teas were done from samples obtained in Chinese stores at Boston. A total of 127 source species of these herbal teas were identified and arranged in two alphabetical lists by the botanical names, each followed by an English common name in parenthesis, part used, frequency in samples, and family. External recognizing characters of medicated teas, discussions of problems encountered in identifying source species, relevant toxicities, and potential new vegetal pharmaceutical resources are given.

APA, Harvard, Vancouver, ISO, and other styles

6

Gregory, V., W. Lim, K. Cameron, M. Bennett, S. Marozin, A. Klimov, H. Hall, N. Cox, A. Hay, and Y. P. Lin. "Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs." Journal of General Virology 82, no. 6 (June 1, 2001): 1397–406. http://dx.doi.org/10.1099/0022-1317-82-6-1397.

Full text

Abstract:

Influenza virus A/Hong Kong/1774/99, isolated from a young child with mild influenza, was shown to be similar in its antigenic and genetic characteristics to H3N2 viruses circulating in pigs in Europe during the 1990s and in particular to be closely related to viruses isolated from two children in the Netherlands in 1993. Similar viruses had previously not been identified outside Europe. Although there is little evidence as to how the child contracted the infection, it appears likely that pigs in southern China were the source of infection. Characteristics shared with the European swine viruses include resistance to the anti-influenza drugs amantadine and rimantadine. Thus not only does this incident once again highlight the potential of pigs as a source of novel human influenza viruses, but also indicates the potential for emergence of amantadine-resistant human viruses.

APA, Harvard, Vancouver, ISO, and other styles

7

Cheung, Chau-kiu, and Steven Sek-yum Ngai. "Predicting drug-free days among at-risk youth." Journal of Social Work 17, no. 5 (May 31, 2016): 599–615. http://dx.doi.org/10.1177/1468017316651990.

Full text

Abstract:

Summary Whether or not at-risk youth eschew illicit drugs because of its expected harm remains uncertain. In theory, expectancy is influential when the harm is valuable to the youth. Hence, to examine this possibility, this study employed a prospective design to collect data from 169 at-risk youths identified by social workers in Hong Kong, China. Findings Results revealed that when a youth has higher expectancy and valuation of harm in the baseline survey, he/she had considerably more drug-free days in the follow-up survey. However, neither the expectancy nor valuation alone introduced an effect on drug-free days. Applications These results sustained approaches to fostering the expectancy and valuation of harm for effective drug rehabilitation. Specifically, the approaches required to raise the expectancy of youth on the harm of drug abuse to their vigour and the value of sustaining their vigour simultaneously.

APA, Harvard, Vancouver, ISO, and other styles

8

Zhai, Fei, Yuxuan Zhai, Chuang Cong, Tingyan Song, Rongwu Xiang, Tianyi Feng, Zhengxuan Liang, et al. "Research Progress of Coronavirus Based on Bibliometric Analysis." International Journal of Environmental Research and Public Health 17, no. 11 (May 26, 2020): 3766. http://dx.doi.org/10.3390/ijerph17113766.

Full text

Abstract:

Background: COVID-19 has become one of the most serious global epidemics in the 21st Century. This study aims to explore the distribution of research capabilities of countries, institutions, and researchers, and the hotspots and frontiers of coronavirus research in the past two decades. In it, references for funding support of urgent projects and international cooperation among research institutions are provided. Method: the Web of Science core collection database was used to retrieve the documents related to coronavirus published from 2003 to 2020. Citespace.5.6.R2, VOSviewer1.6.12, and Excel 2016 were used for bibliometric analysis. Results: 11,036 documents were retrieved, of which China and the United States have contributed the most coronavirus studies, Hong Kong University being the top contributor. Regarding journals, the Journal of Virology has contributed the most, while in terms of researchers, Yuen Kwok Yung has made the most contributions. The proportion of documents published by international cooperation has been rising for decades. Vaccines for SARS-CoV-2 are under development, and clinical trials of several drugs are ongoing. Conclusions: international cooperation is an important way to accelerate research progress and achieve success. Developing corresponding vaccines and drugs are the current hotspots and research directions.

APA, Harvard, Vancouver, ISO, and other styles

9

Qiu, Jane. "One world, one health: combating infectious diseases in the age of globalization." National Science Review 4, no. 3 (May 1, 2017): 493–99. http://dx.doi.org/10.1093/nsr/nwx047.

Full text

Abstract:

Abstract There has been a resurgence of the H7N9 bird-flu virus in China since last winter, resulting in over 460 human infections—the largest number since the first outbreak in 2013—raising serious concerns about its further spread and the effectiveness of existing anti-viral drugs. This is just the latest example of the increasing threat from emerging infectious diseases. Due to a combination of factors related to farming practices, human behaviour, international travel, globalization and climate change, there has been a succession of such pandemics in recent years, such as Severe Acute Respiration Syndrome (SARS), Nipah, Middle East Respiratory Syndrome (MERS), Ebola and Zika, posing an unprecedented challenge to scientists and health workers worldwide. In a forum organized by National Science Review at the World Life Science Conference last November, an international panel of scientists discussed the lessons that have learned from a string of pandemics in recent years, the importance of international collaboration and sharing research benefits more equitably, why there is an urgent need to move towards the one-health approach, and how China could play a leading role in the global effort to combat infectious diseases. Gregory Gray Duke University, USA; Duke Kunshan University, China; Duke-NUS Medical School, Singapore Linfa Wang Duke-NUS Medical School, Singapore Peter Horby Center for Tropical Medicine and Global Health, University of Oxford, UK Fujie Zhang Capital Medical University, Beijing Titan Hospital, China Malik Peiris University of Hong Kong, China George Fu Gao Deputy Director General of the Chinese Centre for Disease Control and Prevention; Institute of Microbiology, Chinese Academy of Sciences, China

APA, Harvard, Vancouver, ISO, and other styles

10

Lazareva, N. B. "Influenza in the COVID-19 era: principles of modern pharmacotherapy." Meditsinskiy sovet = Medical Council, no. 16 (October 30, 2021): 100–108. http://dx.doi.org/10.21518/2079-701x-2021-16-100-108.

Full text

Abstract:

Influenza is one of the most common infectious diseases and a significant public health problem. Every year, the influenza virus causes 3–5 million severe cases, millions hospitalizations and approximately 650,000 deaths. According to WHO four new influenza strains are projected to circulate in the 2020–2021 epidemic season. Influenza A and B strains are: A/Guangdong-Maonan/ SWL1536/2019 (H1N1) pdm09, A/Hong Kong/2671/2019 (H3N2), B/Washington/02/2019 (Victoria lineage), B/ Phuket/3073/2013 (Yamagata lineage). In this context, the problem of prescribing rational antiviral therapy is particularly importance. COVID-19, along with influenza, is a group of respiratory viral infections, but important differences exist in terms of viral agents and the spread of infection. Important differences include the rate of transmission. The average incubation period and generation time (the time between infecting one person and infecting another) for influenza are shorter. COVID-19 may be more severe, causing complications and deaths in 3–4% of cases. The estimated generation time for COVID 19 is 5-6 days, while for influenza it is 3 days. According to the latest data, the reproductive number, i.e., the number of people who can be infected by one patient, is in the range of 2 to 2.5 in COVID 19, which is higher than in influenza. Only a laboratory test can accurately identify the type of pathogen and distinguish it from influenza and other respiratory viruses. Neuraminidase inhibitors are currently first-line drugs recommended by WHO for the treatment and prevention of influenza.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Drugs Prescribing China Hong Kong"

1

Yiu, Kar-lok, and 姚嘉諾. "Clinical research and drug prescription patterns among private practitioners in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B45010547.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hung, Yik-fong Caroline, and 洪益芳. "A survey of albumin use by surgeons and ICU doctors in Hong Kong public hospitals." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B45010055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wong, Ho-cheong, and 黃浩昌. "Frequent attendance for upper respiratory infection in university health service: a retrospective study." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B39724645.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lo, Chiu-sing, and 勞超成. "Territory-wide Antibiotic Stewardship Programme and its effectiveness in public hospitals in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B39724505.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kwan, Ming-tak Kalwan, and 關明德. "Drugs, peers, gangs, and crime: an interactional model." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1995. http://hub.hku.hk/bib/B43893636.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chung, Wai-yee Ivis, and 鍾慧儀. "A study of the drug policy of the Hong Kong Hospital Authority." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B3644828X.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Cheung, Hing-fu, and 張興富. "Attempted suicide by drug overdose in Hong Kong: what are the differences between impulsive and non-impulsivesuicide attempters?" Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45171257.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Chung, Wai-yee Ivis. "A study of the drug policy of the Hong Kong Hospital Authority." Click to view the E-thesis via HKUTO, 2006. http://sunzi.lib.hku.hk/hkuto/record/B3644828X.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Chan, Kin-yi Ivy, and 陳健儀. "A study of determinants of relapse in psychotropic substance abuse." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1995. http://hub.hku.hk/bib/B31250038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Cheng, Man-ying, and 鄭文瑛. "Prescribing pattern of imatinib among chronic phase chronic myeloid leukaemia (CML) patients and its financial impact on Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/196548.

Full text

Abstract:

Background: Chronic myeloid leukaemia (CML) is a haematological malignant disease involving haematopoietic stem cells. It is caused by a known reciprocal chromosomal t(9;22)(q34;q11) translocation, or known as Philadelphia chromosome. The translocation results in the formation of a chimeric BCR-ABL fusion gene. In the most recent guidelines published by NCCN and European LeukemiaNet in 2013, tyrosine kinase inhibitors (TKI) specifically inhibiting the Bcr-Abl tyrosine kinase, are the first-line therapy for patients with chronic phase CML. Imatinib is the oldest among the 3 TKI, and is the most commonly prescribed. Despite its proven therapeutic role in CML, imatinib is a drug of extreme high cost. Estimated annual drug cost is HKD$223,380for a standard 400mg adult daily dose. Therefore, this study aims to survey on the prescribing pattern of imatinib in CML patients, its funding status, response; and estimate its economic burden on the Hong Kong population. Methodology: This is a retrospective patient chart review study. All patients who were diagnosed with CML from 2003 to 2012 and were managed in QMH or QEH were reviewed. Electronic records were retrieved to see whether imatinib was started as first-line treatment within 6 months of diagnosis. The reasons for not initiating imatinib were also investigated. Patients’ response to imatinib, and funding source for the drug, were documented. Annual drug cost of imatinib was estimated from all CML patients who attended all Hospital Authority institutions in 2012 who were prescribed with the drug. Results: Total 153 patients from the 2 institutions were reviewed. One hundred twenty four (81%) of them started imatinib as first-line therapy within 6 months of diagnosis. Nine patients started second generation TKI as first-line. Among those who did not start TKI, the most common reasons are patient preference (3.9%) and financial difficulties (3.3%). Twelve paediatric patients are identified, and all but one of them started imatinib. Seventy one% patients on imatinib experienced side effects. Most frequently reported adverse reactions are thrombocytopenia, oedema and neutropenia. Twenty eight% switched to second generation TKI due to suboptimal response or intoleranceto imatinib. During their course of treatment, 46.3% patients on imatinib require social subsidy from Samaritan Fund. From the dispensing records, the average drug cost per patient per year is HK$113,902. The estimated annual cost burden on the whole Hong Kong population is HK$43,425,878. Conclusion: The prescribing rate of imatinib in chronic phase CML patients in Hong Kong is comparable to overseas prescribing rate. The drug has become a significant financial burden to patients’ family and the society as a whole.
published_or_final_version
Paediatrics and Adolescent Medicine
Master
Master of Medical Sciences

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Drugs Prescribing China Hong Kong"

1

Shek, Daniel T. L., Joav Merrick, and Rachel C. F. Sun. Drug abuse in Hong Kong: Development and evaluation of a prevention program. Hauppauge, N.Y: Nova Science, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cheung, Yuet Wah, and Nicole Wai-ting Cheung. Psychoactive Drug Abuse in Hong Kong: Life Satisfaction and Drug Use. Springer, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Cheung, Yuet Wah, and Nicole Wai-ting Cheung. Psychoactive Drug Abuse in Hong Kong: Life Satisfaction and Drug Use. Springer, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Drugs Prescribing China Hong Kong"

1

Meyer, David R. "Hong Kong’s Enduring Global Business Relations." In Hong Kong in the Cold War. Hong Kong University Press, 2017. http://dx.doi.org/10.5790/hongkong/9789888208005.003.0004.

Full text

Abstract:

By the late twentieth century, Hong Kong had entered the public and private consciousness as one of the world’s greatest business centers. In the background looms its mysterious past as a port in the “Orient,” a place of intrigue, trade, shipping, and smuggling of drugs and gold. This chapter develops the argument about the social networks of capital, and it is integrated with an interpretation of Hong Kong’s rise as the decision-making, management center of Asia from the 1840s to the early twentieth century. Then, the city’s transformation during the Cold War era is examined, and this sets the base for interpreting Hong Kong’s current position as corporate management and business services center of the Asia-Pacific. The discussion of several recent examples of the city’s enhanced integration with mainland China points to possible trends that may impact the city’s future. Finally, an examination of threats to Hong Kong since 1950 highlight how the city’s political-economy has maintained resilience under uncertain conditions.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!